Algae-C Identifies 100 Pharma Molecules Produced by Proprietary Microalgae

Since 2015 Algae-C, a Canadian developer of a novel Carbon-Negative, Algae-based Biomanufacturing Platform has been focused on one goal: revolutionizing the biomanufacturing industry.  The company has invested over $10 million in research to reprogram the…


Algae-C featured on Forbes.com

John Cumbers, senior contributor for Forbes and host of the synbiobeta podcast has featured Algae-C in the article Algae… Nature’s Cost-Effective, Sustainable Biofactories. The simplicity of algae and their relatively inexpensive life cycle requirements (light,…


Algae-C Wins 2021 Algae Industry Award

Algae-C is proud to announce our win from the US-based Algae Biomass Organization at their 2021 Algae Industry Awards for Breakthrough Product – For groundbreaking innovation using algae as part of novel solutions for global problems…

Back to top